Panray Corp. Sub Ormont Drug and Chemical Co., Inc., et al. Propose Withdrawal of FDA Approval for Three New Drug Applications

Summary

The US Food and Drug Administration (FDA) is proposing to withdraw approval of three new drug applications submitted by Ormont Drug and Chemical Co., Inc., following repeated failure to submit required annual reports, and is offering NDA holders the chance to request a hearing on the proposal.